Randhawa Simrat bought DNTH
June 1, 2026 · Form 4 insider transaction
Randhawa Simrat bought 6,908 shares of Dianthus Therapeutics, Inc. at $17.88 per share, a transaction worth $123.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,908
Price
$17.88
Total value
$123.5K
InsiderRandhawa Simrat
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after14,906
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.